UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:NF1-TRMT61B |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: NF1-TRMT61B | FusionPDB ID: 58713 | FusionGDB2.0 ID: 58713 | Hgene | Tgene | Gene symbol | NF1 | TRMT61B | Gene ID | 4763 | 55006 |
Gene name | neurofibromin 1 | tRNA methyltransferase 61B | |
Synonyms | NFNS|VRNF|WSS | - | |
Cytomap | 17q11.2 | 2p23.2 | |
Type of gene | protein-coding | protein-coding | |
Description | neurofibrominneurofibromatosis 1neurofibromatosis-related protein NF-1truncated neurofibromin 1 | tRNA (adenine(58)-N(1))-methyltransferase, mitochondrialmRNA methyladenosine-N(1)-methyltransferasepotential tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRMT61Bpotential tRNA (adenine-N(1)-)-methyltransferase catalytic subunit TRMT61Bt | |
Modification date | 20200322 | 20200313 | |
UniProtAcc | P21359 | . | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000356175, ENST00000358273, ENST00000431387, ENST00000417592, ENST00000444181, ENST00000581113, | ENST00000484060, ENST00000306108, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 47 X 26 X 21=25662 | 1 X 1 X 1=1 |
# samples | 69 | 1 | |
** MAII score | log2(69/25662*10)=-5.21689344093196 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(1/1*10)=3.32192809488736 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: NF1 [Title/Abstract] AND TRMT61B [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | NF1(29497015)-TRMT61B(29084174), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | NF1-TRMT61B seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. NF1-TRMT61B seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. NF1-TRMT61B seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. NF1-TRMT61B seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | NF1 | GO:0043547 | positive regulation of GTPase activity | 2121371 |
Tgene | TRMT61B | GO:0051260 | protein homooligomerization | 23097428 |
Tgene | TRMT61B | GO:0070901 | mitochondrial tRNA methylation | 23097428 |
Tgene | TRMT61B | GO:0080009 | mRNA methylation | 29107537 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | LGG | TCGA-FG-7643-01A | NF1 | chr17 | 29497015 | - | TRMT61B | chr2 | 29084174 | - |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000356175 | NF1 | chr17 | 29497015 | - | ENST00000306108 | TRMT61B | chr2 | 29084174 | - | 1979 | 969 | 254 | 1600 | 448 |
ENST00000358273 | NF1 | chr17 | 29497015 | - | ENST00000306108 | TRMT61B | chr2 | 29084174 | - | 1979 | 969 | 254 | 1600 | 448 |
ENST00000431387 | NF1 | chr17 | 29497015 | - | ENST00000306108 | TRMT61B | chr2 | 29084174 | - | 1929 | 919 | 204 | 1550 | 448 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000356175 | ENST00000306108 | NF1 | chr17 | 29497015 | - | TRMT61B | chr2 | 29084174 | - | 0.000244537 | 0.99975544 |
ENST00000358273 | ENST00000306108 | NF1 | chr17 | 29497015 | - | TRMT61B | chr2 | 29084174 | - | 0.000244537 | 0.99975544 |
ENST00000431387 | ENST00000306108 | NF1 | chr17 | 29497015 | - | TRMT61B | chr2 | 29084174 | - | 0.000223947 | 0.99977607 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >58713_58713_1_NF1-TRMT61B_NF1_chr17_29497015_ENST00000356175_TRMT61B_chr2_29084174_ENST00000306108_length(amino acids)=448AA_BP=238 MGACTPQTLSLPLPSPQPPLPALFPAQGAGPPFPPPPPGRGEDMAAHRPVEWVQAVVSRFDEQLPIKTGQQNTHTKVSTEHNKECLINIS KYKFSLVISGLTTILKNVNNMRIFGEAAEKNLYLSQLIILDTLEKCLAGQPKDTMRLDETMLVKQLLPEICHFLHTCREGNQHAAELRNS ASGVLFSLSCNNFNAVFSRISTRLQELTVCSEDNVDVHDIELLQYINVDCAKLKRLLKVGSQGRVISFEVRKDHHDLAKKNYKHWRDSWK LSHVEEWPDNVDFIHKDISGATEDIKSLTFDAVALDMLNPHVTLPVFYPHLKHGGVCAVYVVNITQVIELLDGIRTCELALSCEKISEVI -------------------------------------------------------------- >58713_58713_2_NF1-TRMT61B_NF1_chr17_29497015_ENST00000358273_TRMT61B_chr2_29084174_ENST00000306108_length(amino acids)=448AA_BP=238 MGACTPQTLSLPLPSPQPPLPALFPAQGAGPPFPPPPPGRGEDMAAHRPVEWVQAVVSRFDEQLPIKTGQQNTHTKVSTEHNKECLINIS KYKFSLVISGLTTILKNVNNMRIFGEAAEKNLYLSQLIILDTLEKCLAGQPKDTMRLDETMLVKQLLPEICHFLHTCREGNQHAAELRNS ASGVLFSLSCNNFNAVFSRISTRLQELTVCSEDNVDVHDIELLQYINVDCAKLKRLLKVGSQGRVISFEVRKDHHDLAKKNYKHWRDSWK LSHVEEWPDNVDFIHKDISGATEDIKSLTFDAVALDMLNPHVTLPVFYPHLKHGGVCAVYVVNITQVIELLDGIRTCELALSCEKISEVI -------------------------------------------------------------- >58713_58713_3_NF1-TRMT61B_NF1_chr17_29497015_ENST00000431387_TRMT61B_chr2_29084174_ENST00000306108_length(amino acids)=448AA_BP=238 MGACTPQTLSLPLPSPQPPLPALFPAQGAGPPFPPPPPGRGEDMAAHRPVEWVQAVVSRFDEQLPIKTGQQNTHTKVSTEHNKECLINIS KYKFSLVISGLTTILKNVNNMRIFGEAAEKNLYLSQLIILDTLEKCLAGQPKDTMRLDETMLVKQLLPEICHFLHTCREGNQHAAELRNS ASGVLFSLSCNNFNAVFSRISTRLQELTVCSEDNVDVHDIELLQYINVDCAKLKRLLKVGSQGRVISFEVRKDHHDLAKKNYKHWRDSWK LSHVEEWPDNVDFIHKDISGATEDIKSLTFDAVALDMLNPHVTLPVFYPHLKHGGVCAVYVVNITQVIELLDGIRTCELALSCEKISEVI -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr17:29497015/chr2:29084174) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
NF1 | . |
FUNCTION: Stimulates the GTPase activity of Ras. NF1 shows greater affinity for Ras GAP, but lower specific activity. May be a regulator of Ras activity. {ECO:0000269|PubMed:2121371, ECO:0000269|PubMed:8417346}. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | TRMT61B | chr17:29497015 | chr2:29084174 | ENST00000306108 | 1 | 7 | 278_279 | 267.3333333333333 | 478.0 | Region | S-adenosyl-L-methionine binding | |
Tgene | TRMT61B | chr17:29497015 | chr2:29084174 | ENST00000306108 | 1 | 7 | 334_337 | 267.3333333333333 | 478.0 | Region | Substrate | |
Tgene | TRMT61B | chr17:29497015 | chr2:29084174 | ENST00000306108 | 1 | 7 | 358_365 | 267.3333333333333 | 478.0 | Region | Substrate |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | NF1 | chr17:29497015 | chr2:29084174 | ENST00000356175 | - | 5 | 57 | 1352_1355 | 195.33333333333334 | 2819.0 | Compositional bias | Note=Poly-Ser |
Hgene | NF1 | chr17:29497015 | chr2:29084174 | ENST00000358273 | - | 5 | 58 | 1352_1355 | 195.33333333333334 | 2840.0 | Compositional bias | Note=Poly-Ser |
Hgene | NF1 | chr17:29497015 | chr2:29084174 | ENST00000431387 | - | 5 | 15 | 1352_1355 | 195.33333333333334 | 594.0 | Compositional bias | Note=Poly-Ser |
Hgene | NF1 | chr17:29497015 | chr2:29084174 | ENST00000356175 | - | 5 | 57 | 1235_1451 | 195.33333333333334 | 2819.0 | Domain | Ras-GAP |
Hgene | NF1 | chr17:29497015 | chr2:29084174 | ENST00000356175 | - | 5 | 57 | 1580_1738 | 195.33333333333334 | 2819.0 | Domain | CRAL-TRIO |
Hgene | NF1 | chr17:29497015 | chr2:29084174 | ENST00000358273 | - | 5 | 58 | 1235_1451 | 195.33333333333334 | 2840.0 | Domain | Ras-GAP |
Hgene | NF1 | chr17:29497015 | chr2:29084174 | ENST00000358273 | - | 5 | 58 | 1580_1738 | 195.33333333333334 | 2840.0 | Domain | CRAL-TRIO |
Hgene | NF1 | chr17:29497015 | chr2:29084174 | ENST00000431387 | - | 5 | 15 | 1235_1451 | 195.33333333333334 | 594.0 | Domain | Ras-GAP |
Hgene | NF1 | chr17:29497015 | chr2:29084174 | ENST00000431387 | - | 5 | 15 | 1580_1738 | 195.33333333333334 | 594.0 | Domain | CRAL-TRIO |
Hgene | NF1 | chr17:29497015 | chr2:29084174 | ENST00000356175 | - | 5 | 57 | 2555_2571 | 195.33333333333334 | 2819.0 | Motif | Note=Bipartite nuclear localization signal |
Hgene | NF1 | chr17:29497015 | chr2:29084174 | ENST00000358273 | - | 5 | 58 | 2555_2571 | 195.33333333333334 | 2840.0 | Motif | Note=Bipartite nuclear localization signal |
Hgene | NF1 | chr17:29497015 | chr2:29084174 | ENST00000431387 | - | 5 | 15 | 2555_2571 | 195.33333333333334 | 594.0 | Motif | Note=Bipartite nuclear localization signal |
Hgene | NF1 | chr17:29497015 | chr2:29084174 | ENST00000356175 | - | 5 | 57 | 1580_1837 | 195.33333333333334 | 2819.0 | Region | Note=Lipid binding |
Hgene | NF1 | chr17:29497015 | chr2:29084174 | ENST00000358273 | - | 5 | 58 | 1580_1837 | 195.33333333333334 | 2840.0 | Region | Note=Lipid binding |
Hgene | NF1 | chr17:29497015 | chr2:29084174 | ENST00000431387 | - | 5 | 15 | 1580_1837 | 195.33333333333334 | 594.0 | Region | Note=Lipid binding |
Tgene | TRMT61B | chr17:29497015 | chr2:29084174 | ENST00000306108 | 1 | 7 | 133_179 | 267.3333333333333 | 478.0 | Region | Substrate | |
Tgene | TRMT61B | chr17:29497015 | chr2:29084174 | ENST00000306108 | 1 | 7 | 206_207 | 267.3333333333333 | 478.0 | Region | Substrate | |
Tgene | TRMT61B | chr17:29497015 | chr2:29084174 | ENST00000306108 | 1 | 7 | 228_232 | 267.3333333333333 | 478.0 | Region | Substrate | |
Tgene | TRMT61B | chr17:29497015 | chr2:29084174 | ENST00000306108 | 1 | 7 | 253_260 | 267.3333333333333 | 478.0 | Region | Substrate | |
Tgene | TRMT61B | chr17:29497015 | chr2:29084174 | ENST00000306108 | 1 | 7 | 77_79 | 267.3333333333333 | 478.0 | Region | Substrate |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
NF1 | HRAS, SMARCA4, POLR2A, TIRAP, SIRT7, VCP, NSFL1C, CAV1, YWHAB, FAF2, NXF1, CCDC8, HLA-DPA1, EFNB2, CD274, TNFSF13B, CA14, SLAMF1, VSIG4, TGOLN2, HTR6, NOSIP, KRAS, CLK1, CDC5L, APP, YWHAH, PML, TRAF6, PTEN, SDC2, EGFR, CD79B, P4HA3, SCN3B, VSIG1, SIGLECL1, EPHA1, FAM174A, KCTD3, KIF13B, ZBTB21, KSR1, CGN, GIGYF1, LRFN1, RTKN, MAST3, DENND1A, SH3PXD2A, SRGAP2, DENND4C, PPM1H, EIF4E2, SIPA1L1, LIMA1, RALGPS2, MAGI1, CBY1, TESK2, CDC25C, DCLK1, GIGYF2, HDAC4, LPIN3, ZNF638, CAMSAP2, NADK, MAPKAP1, SRSF12, RASAL2, SYDE1, KIAA1804, TIAM1, AGAP1, CDC25B, CDK16, SH3RF3, PHLDB2, PLEKHA7, KIF1C, OSBPL6, FAM110B, USP21, NAV1, TANC2, PTPN13, FAM53C, ANKRD34A, STARD13, PTPN14, GAB2, DENND4A, INPP5E, TOP1, TOP2A, TOP3A, NRAS, ZUFSP, ESR2, LZTR1, SPRED1, MYC, LIMK2, KIAA1429, CTDP1, DYRK1A, F12, AKT1, EPHA2, MAP2K3, RAF1, SOX4, BIRC3, ORF7a, LCK, NOLC1, N, nsp7, KIF14, PRC1, MKI67, FASN, NR3C1, DDRGK1, FLOT1, LYN, PFN1, RHOB, ATG7, EFS, C19orf38, CDHR2, ITFG3, CD80, SEMA4C, DGCR2, EFNA4, PTGES2, LRRC25, EVI2A, EFNB1, TPST2, C3orf18, GYPA, HCST, TACSTD2, OPALIN, IL2RA, CD226, SIRT6, |
![]() |
Gene | STRING network |
NF1 | ![]() |
TRMT61B |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to NF1-TRMT61B |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to NF1-TRMT61B |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | NF1 | C0027831 | Neurofibromatosis 1 | 44 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | NF1 | C1708353 | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 10 | CLINGEN |
Hgene | NF1 | C0349639 | Juvenile Myelomonocytic Leukemia | 7 | CTD_human;GENOMICS_ENGLAND;ORPHANET |
Hgene | NF1 | C2931482 | Neurofibromatosis-Noonan syndrome | 6 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | NF1 | C0553586 | Cafe-au-lait macules with pulmonary stenosis | 5 | CTD_human;GENOMICS_ENGLAND;ORPHANET |
Hgene | NF1 | C0162678 | Neurofibromatoses | 3 | CGI;CTD_human;GENOMICS_ENGLAND |
Hgene | NF1 | C0004114 | Astrocytoma | 2 | CTD_human |
Hgene | NF1 | C0023467 | Leukemia, Myelocytic, Acute | 2 | CTD_human |
Hgene | NF1 | C0025202 | melanoma | 2 | CGI;CTD_human |
Hgene | NF1 | C0026998 | Acute Myeloid Leukemia, M1 | 2 | CTD_human |
Hgene | NF1 | C0205768 | Subependymal Giant Cell Astrocytoma | 2 | CTD_human |
Hgene | NF1 | C0206727 | Nerve Sheath Tumors | 2 | CTD_human |
Hgene | NF1 | C0280783 | Juvenile Pilocytic Astrocytoma | 2 | CTD_human |
Hgene | NF1 | C0280785 | Diffuse Astrocytoma | 2 | CTD_human |
Hgene | NF1 | C0334579 | Anaplastic astrocytoma | 2 | CTD_human |
Hgene | NF1 | C0334580 | Protoplasmic astrocytoma | 2 | CTD_human |
Hgene | NF1 | C0334581 | Gemistocytic astrocytoma | 2 | CTD_human |
Hgene | NF1 | C0334582 | Fibrillary Astrocytoma | 2 | CTD_human |
Hgene | NF1 | C0334583 | Pilocytic Astrocytoma | 2 | CTD_human |
Hgene | NF1 | C0338070 | Childhood Cerebral Astrocytoma | 2 | CTD_human |
Hgene | NF1 | C0547065 | Mixed oligoastrocytoma | 2 | CTD_human |
Hgene | NF1 | C0750935 | Cerebral Astrocytoma | 2 | CTD_human |
Hgene | NF1 | C0750936 | Intracranial Astrocytoma | 2 | CTD_human |
Hgene | NF1 | C0751689 | Peripheral Nerve Sheath Neoplasm | 2 | CTD_human |
Hgene | NF1 | C0751691 | Perineurioma | 2 | CTD_human |
Hgene | NF1 | C1704230 | Grade I Astrocytoma | 2 | CTD_human |
Hgene | NF1 | C1834235 | NEUROFIBROMATOSIS, FAMILIAL SPINAL | 2 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | NF1 | C1879321 | Acute Myeloid Leukemia (AML-M2) | 2 | CTD_human |
Hgene | NF1 | C0001430 | Adenoma | 1 | CTD_human |
Hgene | NF1 | C0004352 | Autistic Disorder | 1 | CTD_human |
Hgene | NF1 | C0016057 | Fibrosarcoma | 1 | CTD_human |
Hgene | NF1 | C0017636 | Glioblastoma | 1 | CTD_human |
Hgene | NF1 | C0017638 | Glioma | 1 | CGI;CTD_human |
Hgene | NF1 | C0020796 | Profound Mental Retardation | 1 | CTD_human |
Hgene | NF1 | C0023186 | Learning Disorders | 1 | CTD_human |
Hgene | NF1 | C0023827 | liposarcoma | 1 | CTD_human |
Hgene | NF1 | C0025363 | Mental Retardation, Psychosocial | 1 | CTD_human |
Hgene | NF1 | C0026654 | Moyamoya Disease | 1 | GENOMICS_ENGLAND |
Hgene | NF1 | C0027809 | Neurilemmoma | 1 | CTD_human |
Hgene | NF1 | C0027830 | neurofibroma | 1 | CTD_human |
Hgene | NF1 | C0027962 | Melanocytic nevus | 1 | CTD_human |
Hgene | NF1 | C0028326 | Noonan Syndrome | 1 | GENOMICS_ENGLAND |
Hgene | NF1 | C0031511 | Pheochromocytoma | 1 | CTD_human |
Hgene | NF1 | C0035320 | Retinal Neovascularization | 1 | CTD_human |
Hgene | NF1 | C0205646 | Adenoma, Basal Cell | 1 | CTD_human |
Hgene | NF1 | C0205647 | Follicular adenoma | 1 | CTD_human |
Hgene | NF1 | C0205648 | Adenoma, Microcystic | 1 | CTD_human |
Hgene | NF1 | C0205649 | Adenoma, Monomorphic | 1 | CTD_human |
Hgene | NF1 | C0205650 | Papillary adenoma | 1 | CTD_human |
Hgene | NF1 | C0205651 | Adenoma, Trabecular | 1 | CTD_human |
Hgene | NF1 | C0205824 | Liposarcoma, Dedifferentiated | 1 | CTD_human |
Hgene | NF1 | C0205825 | Liposarcoma, Pleomorphic | 1 | CTD_human |
Hgene | NF1 | C0205944 | Sarcoma, Epithelioid | 1 | CTD_human |
Hgene | NF1 | C0205945 | Sarcoma, Spindle Cell | 1 | CTD_human |
Hgene | NF1 | C0259783 | mixed gliomas | 1 | CTD_human |
Hgene | NF1 | C0334588 | Giant Cell Glioblastoma | 1 | CTD_human |
Hgene | NF1 | C0555198 | Malignant Glioma | 1 | CTD_human |
Hgene | NF1 | C0751262 | Adult Learning Disorders | 1 | CTD_human |
Hgene | NF1 | C0751263 | Learning Disturbance | 1 | CTD_human |
Hgene | NF1 | C0751265 | Learning Disabilities | 1 | CTD_human |
Hgene | NF1 | C0751374 | Schwannomatosis, Plexiform | 1 | CTD_human |
Hgene | NF1 | C0917816 | Mental deficiency | 1 | CTD_human |
Hgene | NF1 | C0917817 | Neurofibromatosis 3 | 1 | CTD_human |
Hgene | NF1 | C1257877 | Pheochromocytoma, Extra-Adrenal | 1 | CTD_human |
Hgene | NF1 | C1261473 | Sarcoma | 1 | CTD_human |
Hgene | NF1 | C1330966 | Developmental Academic Disorder | 1 | CTD_human |
Hgene | NF1 | C1370889 | Liposarcoma, well differentiated | 1 | CTD_human |
Hgene | NF1 | C1621958 | Glioblastoma Multiforme | 1 | CTD_human |
Hgene | NF1 | C3150928 | NF1 Microdeletion Syndrome | 1 | ORPHANET |
Hgene | NF1 | C3714756 | Intellectual Disability | 1 | CTD_human |